On Air Now

Current Show

Early Morning Journal   5:30 AM - 6:00 AM

The latest information to get your morning going on the Early Morning Journal

Show Info »

Upcoming Shows

Program Schedule »

Tune in to Listen

1590 AM Coldwater, Michigan 95.5 FM Coldwater, Michigan

Weather

Current Conditions(Coldwater,MI 49036)

More Weather »
43° Feels Like: °
Wind: E mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Mostly Sunny 71°

Tonight

Clear 46°

Tomorrow

Sunny 71°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

Novo Nordisk says completes hemophilia drug trial

COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP.

Novo Nordisk said in a statement that in patients given the drug, 99 percent of bleeding episodes were treated with only one infusion and two-thirds of the patients had experienced complete resolution of bleeding.

Patients had also reported an improvement in quality of life during the trial and the drug appeared to have a safe and well-tolerated profile, Novo said in the statement.

(Reporting by Copenhagen Newsroom; Editing by Anthony Barker)

Comments